Identifying Locally Advanced Basal Cell Carcinoma Eligible for Treatment with Vismodegib: An Expert Panel Consensus
- 16 February 2015
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 11 (4) , 703-712
Abstract
Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Most occur on the head and neck, where cosmetic and functional outcomes are critical. BCC can be locally destructive if not diagnosed early and treated appropriately. Surgery is the treatment of choice for the majority of high-risk lesions. Aggressive, recurrent or unresectable tumors can be difficult to manage. Until recently, no approved systemic therapy was available for locally advanced or metastatic BCC inappropriate for surgery or radiotherapy. Vismodegib provides a systemic treatment option. However, a consensus definition of advanced BCC is lacking. A multidisciplinary panel with expertise in oncology, dermatology, dermatologic surgery and radiation oncology proposes a consensus definition based on published evidence and clinical experience.Keywords
This publication has 49 references indexed in Scilit:
- Age distribution of patients with advanced non-melanoma skin cancer in the United StatesArchives of Dermatological Research, 2013
- Basal cell carcinoma epidemiology in the UK: the elephant in the roomClinical and Experimental Dermatology, 2013
- Known and potential new risk factors for skin cancer in European populations: a multicentre case-control studyBritish Journal of Dermatology, 2012
- A systematic review of worldwide incidence of nonmelanoma skin cancerBritish Journal of Dermatology, 2012
- Hereditary tumour syndromes featuring basal cell carcinomasBritish Journal of Dermatology, 2011
- Basal Cell Carcinomas Arise from Hair Follicle Stem Cells in Ptch1+/− MiceCancer Cell, 2011
- Identification of the cell lineage at the origin of basal cell carcinomaNature Cell Biology, 2010
- Basal-Cell CarcinomaNew England Journal of Medicine, 2005
- Aggressive basal cell carcinoma: Presentation, pathogenesis, and managementCancer and Metastasis Reviews, 2004
- Platinum-Based Cytotoxic Therapy in Basal Cell Carcinoma a review of the literatureActa Oncologica, 1996